Document is current
Any future updates will be listed below
-
Authors
Alexeenko, Alina A.
Darwish, Ahmad
Strongrich, Drew
Kazarin, Petr
Patil, Chanakya
Tower, Cole W.
Wheeler, Isaac S.
Munson, Eric
Zhou, Qi
Narsimhan, Vivek
Yoon, Kyu
Nail, Steven L.
Cofer, Anthony
Stanbro, Justin
Renawala, Harshil
Roth, Daniel
DeMarco, Francis
Griffiths, Justin
Peroulis, Dimitrios
-
Funding
Funding for this research was provided by:
National Institute for Innovation in Manufacturing Biopharmaceuticals (PC4.1-307)
Davidson School of Chemical Engineering, Purdue University
- License Information
-
More Information
Article History
Received: 30 March 2024
Accepted: 21 February 2025
First Online: 27 March 2025
Declarations
:
: The authors declare the following competing interests: J.S., H.R., D.R. are employed by Merck & Co. F.D., J.G. and P.K. are employed by IMA Life North America. A.A.A, D.S., A.D., and D.P. are inventors on patents related to this work and hold equity ownership in LyoWave, Inc commercializing the qRF microwave technology. E.M. is a partial owner of Kansas Analytical Services, a company that provides solid-state services to the pharmaceutical industry. The results presented here are from his academic work, and no data from Kansas Analytical Services is shown here. C.P., C.T., Q.Z., V.N., K.Y., and I.S.W. declare no competing interests.
